Related Experiment Video
Updated: Sep 18, 2025
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Genetic Interplay Between Attention-Deficit/Hyperactivity Disorder and Pain Suggests Neurodevelopmental Pathways and
Nicolas P Ciochetti1, Victor F de Oliveira1, Iago Junger-Santos1
1Laboratory of Physiological Genomics of Mental Health, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Background:
In this study, we investigated the genetic connections between attention-deficit/hyperactivity disorder (ADHD), migraine (MGN), and multisite chronic pain (MCP). The goal was to identify specific shared biological mechanisms that contribute to the overlap between ADHD and these pain-related conditions.
Methods:
We utilized various post-genome-wide association study analyses on summary data from samples ranging between 225,534 and 766,345 individuals. In an independent sample of patients with ADHD and control participants (665 cases and 995 controls), we evaluated MGN and MCP polygenic risk scores (PRSs) in relation to comorbid profiles, symptom severity, and neuroimaging brain scores.
Results:
The findings show a strong biological overlap between ADHD and MCP, with a less pronounced relationship with MGN. Key regions and genes associated with ADHD and MCP were enriched in neurodevelopmental pathways, including those involved in neuron projection morphogenesis and nervous system development. Drug-set enrichment analysis identified that some of these pathways are potentially influenced by paracetamol, a drug that has been implicated as a class I environmental risk factor for ADHD when exposure occurs prenatally. Causal inference analysis using a 5-fold larger ADHD summary dataset demonstrated stronger effects of MCP on ADHD than the reverse. In the independent sample, higher MCP PRSs were linked to structural brain features, increased comorbidity with substance use and bipolar disorder, and heightened severity of ADHD symptoms.
Conclusions:
These findings underscore the significant genetic relationship between ADHD and MCP, suggesting that shared genetic factors may influence brain development and contribute to diverse clinical outcomes in ADHD.
More Related Videos
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
01:28Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
01:25Analgesia and Pain Management
01:19Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
01:15Drug Abuse and Addiction: Pharmacological Phenomena
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...